Literature DB >> 22114625

Report of a patient chewing fentanyl patches who was titrated onto methadone.

Eric Dale1, Fleur Ashby, Kalyan Seelam.   

Abstract

This case report discusses the clinical presentation and management of a patient presenting to substance misuse services reporting chewing fentanyl patches in addition to wearing them transdermally. The patient was successfully titrated onto methadone 30 mg. Only one previously reported case of an individual chewing fentanyl patches was found in the literature; no case reports were found where treatment involved titrating the patient onto methadone. The pharmacology and illicit use of fentanyl are also considered.

Entities:  

Year:  2009        PMID： 22114625      PMCID： PMC3029364          DOI： 10.1136/bcr.01.2009.1454

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  11 in total

1.  Transdermal fentanyl abuse and misuse.

Authors:  Mary Lynn Arvanitis; Robert C Satonik
Journal:  Am J Emerg Med       Date:  2002-01       Impact factor: 2.469

2.  Fentanyl dependence associated with oral ingestion.

Authors:  L R Hays; V Stillner; R Littrell
Journal:  Anesthesiology       Date:  1992-10       Impact factor: 7.892

3.  'Designer drugs'. Recognizing and managing their toxic effects.

Authors:  G L Sternbach; J Varon
Journal:  Postgrad Med       Date:  1992-06       Impact factor: 3.840

4.  A fatal overdose of transdermally administered fentanyl.

Authors:  C Kramer; M Tawney
Journal:  J Am Osteopath Assoc       Date:  1998-07

5.  Inhalation abuse of fentanyl patch.

Authors:  K A Marquardt; R S Tharratt
Journal:  J Toxicol Clin Toxicol       Date:  1994

Review 6.  Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.

Authors:  R B Muijsers; A J Wagstaff
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  Fentanyl remaining in a transdermal system following three days of continuous use.

Authors:  K A Marquardt; R S Tharratt; N A Musallam
Journal:  Ann Pharmacother       Date:  1995-10       Impact factor: 3.154

8.  Oral transmucosal abuse of transdermal fentanyl.

Authors:  I A Liappas; N P Dimopoulos; E Mellos; O E Gitsa; A I Liappas; A D Rabavilas
Journal:  J Psychopharmacol       Date:  2004-06       Impact factor: 4.153

9.  Drug abuse in oral and maxillofacial training programs.

Authors:  M Rosenberg
Journal:  J Oral Maxillofac Surg       Date:  1986-06       Impact factor: 1.895

10.  Fatal intravenous fentanyl abuse: four cases involving extraction of fentanyl from transdermal patches.

Authors:  Amy M Tharp; Ruth E Winecker; David C Winston
Journal:  Am J Forensic Med Pathol       Date:  2004-06       Impact factor: 0.921
View more
  3 in total

1.  Quantitative low-volume assay for simultaneous determination of fentanyl, norfentanyl, and minor metabolites in human plasma and urine by liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Authors:  Nina Sophia Mahlke; Victoria Ziesenitz; Gerd Mikus; Gisela Skopp
Journal:  Int J Legal Med       Date:  2014-07-06       Impact factor: 2.686

2.  Transdermal patches: the emerging mode of drug delivery system in psychiatry.

Authors:  Miriam Isaac; Carl Holvey
Journal:  Ther Adv Psychopharmacol       Date:  2012-12

3.  How Resistant to Tampering are Codeine Containing Analgesics on the Market? Assessing the Potential for Opioid Extraction.

Authors:  Andreas Kimergård; Paolo Deluca; Peter Hindersson; Torben Breindahl
Journal:  Pain Ther       Date:  2016-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.